Enzastaurin Before and Concomitant With Radiation Therapy, Followed by Enzastaurin Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma Without Methylation of the Promoter Gene of MGMT Enzyme - a Phase II Study
Phase of Trial: Phase II
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Enzastaurin (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 18 May 2016 Status changed from active, no longer recruiting to completed.
- 08 Apr 2016 Planned End Date changed from 1 Mar 2016 to 1 Mar 2017.
- 01 Apr 2015 Planned End Date changed from 1 Mar 2015 to 1 Mar 2016 as per ClinicalTrials.gov record.